CAM
HALO icon

Capstone Asset Management’s Halozyme HALO Stock Holding History

Capstone Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-10,226
Closed -$113K – 1912
2013
Q3 		$113K Sell
10,226
-50
-0.5% -$417 ﹤0.01% 1939
2013
Q2 		$82K Buy
+10,276
New +$65.4K ﹤0.01% 1911

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capstone Asset Management's HALO Position: Q4 2013 in Review

Capstone Asset Management sold out of Halozyme (HALO) in Q4 2013, closing a stake of 10,226 shares — an estimated $113K sold.

Capstone Asset Management first reported a position in HALO in Q2 2013 and held it in 2 quarters. The position peaked at $113K in Q3 2013. 119 funds tracked by Wall St. Rank hold HALO as of Q4 2013.

  • Capstone Asset Management reported no remaining Halozyme position as of Q4 2013 after selling out during the quarter.
  • Capstone Asset Management sold 10,226 Halozyme shares in Q4 2013, an estimated $113K.
  • Capstone Asset Management first reported a position in Halozyme in Q2 2013 and held it in 2 quarters.
  • Capstone Asset Management's Halozyme position peaked at $113K in Q3 2013.
  • 119 funds tracked by Wall St. Rank held Halozyme as of Q4 2013.

Based on Capstone Asset Management's 13F filing for Q4 2013, filed 4 Feb 2014.